Search research articles
Contact Us
Filters
Showing results (1-10 of 123) with videos related to
Page
of 13
Sort By:
JACC. Cardiovascular Imaging
|
April 17, 2010
Screening for left ventricular systolic dysfunction: is imaging a solution?
John J Atherton
Heart Failure Clinics
|
March 13, 2012
Stage B heart failure: rationale for screening
John J Atherton
Scientifica
|
November 27, 2013
Chronic heart failure: we are fighting the battle, but are we winning the war?
John J Atherton
Cardiac Failure Review
|
August 9, 2017
Should Angiotensin Receptor Neprilysin Inhibitors Replace Angiotensin-converting Enzyme Inhibitors in Heart Failure With a Reduced Ejection Fraction?
Sam Hayman, John J Atherton
Cardiac Failure Review
|
August 9, 2017
Expert Comment: Is Medication Titration in Heart Failure too Complex?
John J Atherton, Annabel Hickey
The Medical Journal of Australia
|
September 30, 2020
Should patients with heart failure listen to their gut?
John J Atherton, Chamindie Punyadeera
Lancet (London, England)
|
May 18, 2021
Quality first in obstructive hypertrophic cardiomyopathy
Sandhir B Prasad, John J Atherton
The Lancet. Global Health
|
January 13, 2024
Learning from our differences: insights from a global heart failure registry
Sandhir B Prasad, John J Atherton
JACC. Cardiovascular Interventions
|
April 24, 2025
First "Minimize" the Harm: Factoring Quality of Life Into the Discourse on Procedural Myocardial Infarction
John J Atherton, Sandhir B Prasad
Heart, Lung & Circulation
|
July 20, 2019
Response to "Paradise Lost? New National Heart Foundation of Australia Guidelines on Heart Failure Fail to Recognise the Intensity of Exercise Evidence"
Tom Briffa, John J Atherton, Cia Connell
Page
of 13
Search research articles
Search
Showing results (1-10 of 123) with videos related to
Sort By:
Page
of 13
JACC. Cardiovascular Imaging
|
April 17, 2010
Screening for left ventricular systolic dysfunction: is imaging a solution?
John J Atherton
Heart Failure Clinics
|
March 13, 2012
Stage B heart failure: rationale for screening
John J Atherton
Scientifica
|
November 27, 2013
Chronic heart failure: we are fighting the battle, but are we winning the war?
John J Atherton
Cardiac Failure Review
|
August 9, 2017
Should Angiotensin Receptor Neprilysin Inhibitors Replace Angiotensin-converting Enzyme Inhibitors in Heart Failure With a Reduced Ejection Fraction?
Sam Hayman, John J Atherton
Cardiac Failure Review
|
August 9, 2017
Expert Comment: Is Medication Titration in Heart Failure too Complex?
John J Atherton, Annabel Hickey
The Medical Journal of Australia
|
September 30, 2020
Should patients with heart failure listen to their gut?
John J Atherton, Chamindie Punyadeera
Lancet (London, England)
|
May 18, 2021
Quality first in obstructive hypertrophic cardiomyopathy
Sandhir B Prasad, John J Atherton
The Lancet. Global Health
|
January 13, 2024
Learning from our differences: insights from a global heart failure registry
Sandhir B Prasad, John J Atherton
JACC. Cardiovascular Interventions
|
April 24, 2025
First "Minimize" the Harm: Factoring Quality of Life Into the Discourse on Procedural Myocardial Infarction
John J Atherton, Sandhir B Prasad
Heart, Lung & Circulation
|
July 20, 2019
Response to "Paradise Lost? New National Heart Foundation of Australia Guidelines on Heart Failure Fail to Recognise the Intensity of Exercise Evidence"
Tom Briffa, John J Atherton, Cia Connell
Page
of 13